{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:49:18Z","timestamp":1790138958888,"version":"4.0.1"},"reference-count":321,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clindermatol.2015.11.013","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T06:30:13Z","timestamp":1448173813000},"page":"214-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Multisystem diseases affecting the skin and eye"],"prefix":"10.1016","volume":"34","author":[{"given":"Karolyn A.","family":"Wanat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.11.013_bb0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11926-996-0012-8","article-title":"Pathogenesis of reactive arthritis","volume":"3","author":"Sieper","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2008.02.047","article-title":"Reiter's syndrome: the classic triad and more","volume":"59","author":"Wu","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0015","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198312293092604","article-title":"Reiter's syndrome and reactive arthritis in perspective","volume":"309","author":"Keat","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0020","first-page":"101","article-title":"Reiter's syndrome and reactive arthritis","volume":"100","author":"Parker","year":"2000","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0025","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0002-9343(79)90739-3","article-title":"A follow-up study of 48 patients with Reiter's syndrome","volume":"67","author":"Butler","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02032342","article-title":"Clinical characteristics in male and female uro-arthritis or Reiter's syndrome","volume":"3","author":"Yli-Kerttula","year":"1984","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.60.4.337","article-title":"Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis","volume":"60","author":"Fendler","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0197-0070(89)90108-3","article-title":"Evidence for Chlamydia trachomatis and Ureaplasma urealyticum in a patient with Reiter's disease","volume":"10","author":"Smith","year":"1989","journal-title":"J Adolesc Health Care"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0045","first-page":"877","article-title":"Ureaplasma urealyticum in Reiter's syndrome","volume":"21","author":"Horowitz","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0050","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/322644","article-title":"Reactive arthritis and Reiter's syndrome following an outbreak of gastroenteritis caused by Salmonella enteritidis","volume":"33","author":"Dworkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0055","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/art.1780230813","article-title":"Reiter's syndrome after Campylobacter jejuni enteritis","volume":"23","author":"Leung","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00152713","article-title":"Epidemic Reiter's syndrome following an outbreak of shigellosis","volume":"2","author":"Finch","year":"1986","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.1985.tb01136.x","article-title":"Study of Reiter's syndrome, with special emphasis on Yersinia enterocolitica","volume":"86","author":"Yu","year":"1985","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/rheumatology\/38.5.411","article-title":"Chlamydia pneumoniae as a triggering infection in reactive arthritis","volume":"38","author":"Hannu","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0075","first-page":"2277","article-title":"Recurrent reactive arthritis associated with urinary tract infection by Escherichia coli","volume":"26","author":"Laasila","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF01971269","article-title":"Clostridium difficile toxin-induced reactive arthritis in a patient with chronic Reiter's syndrome","volume":"11","author":"Cope","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0085","first-page":"795","article-title":"Reactive oligoarthritis in a patient with Clostridium difficile pseudomembranous colitis. Review of the literature","volume":"65","author":"Veillard","year":"1998","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0090","first-page":"90","article-title":"Cross-reactivity between Borrelia burgdorferi and \"arthrogenic\" bacteria in sera from patients with reactive arthritis","volume":"41","author":"Sobieszczanska","year":"1996","journal-title":"Rocz Akad Med Bialymst"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0095","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/anr.1780320902","article-title":"Immune responses to Borrelia burgdorferi in patients with reactive arthritis","volume":"32","author":"Weyand","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00005792-200103000-00002","article-title":"Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature","volume":"80","author":"Jacobs","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/rheumatology\/37.5.581","article-title":"Sacroiliitis in an HLA B27-negative patient following giardiasis","volume":"37","author":"Layton","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7547\/0960362","article-title":"Poststreptococcal reactive arthritis","volume":"96","author":"Logan","year":"2006","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/rheumatology\/keh225","article-title":"Poststreptococcal reactive arthritis: what is it and how do we know?","volume":"43","author":"Mackie","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S1413-86702002000100006","article-title":"Reiter's syndrome associated with the acquired immunodeficiency syndrome: a case report","volume":"6","author":"Malta","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0125","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archderm.1987.01660360050012","article-title":"Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome","volume":"123","author":"Duvic","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-106-1-19","article-title":"The co-occurrence of Reiter's syndrome and acquired immunodeficiency","volume":"106","author":"Winchester","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0889-857X(21)00723-7","article-title":"Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies","volume":"18","author":"Clark","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2298\/VSP0301005P","article-title":"Isolation of Chlamydia trachomatis or Ureaplasma urealyticum from the synovial fluid of patients with Reiter's syndrome","volume":"60","author":"Pavlica","year":"2003","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0145","first-page":"571","article-title":"HL-A 27 in Reiter's syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression","volume":"11","author":"McClusky","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0950-3579(98)80038-1","article-title":"The immunogenetics of the seronegative spondyloarthropathies","volume":"12","author":"al-Khonizy","year":"1998","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0889-857X(05)70037-5","article-title":"Reiter's syndrome. Diagnosis and clinical features","volume":"24","author":"Amor","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0160","first-page":"437","article-title":"Reiter's syndrome\u2014analysis of 187 patients","volume":"54","author":"Pavlica","year":"1997","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0165","first-page":"285","article-title":"Juvenile onset Reiter's syndrome. A retrospective study of 26 patients","volume":"10","author":"Cuttica","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/art.1780240612","article-title":"Reiter's syndrome. Evaluation of preliminary criteria for definite disease","volume":"24","author":"Willkens","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0175","first-page":"232","article-title":"Reiter's aortitis with pericardial fluid, heart block and neurologic manifestations","volume":"6","author":"Unverferth","year":"1979","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000045566","article-title":"IgA nephropathy and Reiter's syndrome. Report of two cases and review of the literature","volume":"84","author":"Satko","year":"2000","journal-title":"Nephron"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2015.11.013_bb0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/ard.38.Suppl_1.68","article-title":"Keratodermia blennorrhagica and mucocutaneous manifestations of Reiter's syndrome","volume":"38","author":"Calin","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0190-9622(79)80056-0","article-title":"The spectrum of Reiter's disease","volume":"1","author":"Callen","year":"1979","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0733-8635(18)30307-3","article-title":"Oculocutaneous manifestations observed in multisystem disorders","volume":"10","author":"Callen","year":"1992","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1468-3083.2004.01045.x","article-title":"Reiter syndrome accompanied by Terry nail","volume":"19","author":"Coskun","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0161-6420(86)33747-3","article-title":"The clinical diagnosis of Reiter's syndrome. Ophthalmic and nonophthalmic aspects","volume":"93","author":"Lee","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/0002-9394(71)90563-0","article-title":"Reiter's syndrome","volume":"71","author":"Ostler","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009253","article-title":"Bilateral multifocal posterior pole lesions in Reiter syndrome","volume":"2013","author":"Mansour","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0220","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3341\/kjo.2010.24.5.310","article-title":"Macular infarction associated with reactive arthritis","volume":"24","author":"Kim","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0225","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0161-6420(03)00620-1","article-title":"Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome","volume":"110","author":"Kiss","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.504","article-title":"Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays","volume":"46","author":"Sieper","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0235","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02207965","article-title":"HLA B27 and clinical features in Reiter's syndrome","volume":"11","author":"Tuncer","year":"1992","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0240","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0245","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.59.7.565","article-title":"Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis","volume":"59","author":"Yli-Kerttula","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0250","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.62.9.880","article-title":"Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis","volume":"62","author":"Yli-Kerttula","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/ard.62.7.655","article-title":"Antibiotic treatment and long term prognosis of reactive arthritis","volume":"62","author":"Laasila","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0260","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/art.1780391211","article-title":"Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs cooperative study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0265","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2177\/jsci.33.283","article-title":"Efficacy of methotrexate in the treatment of a HLA-B27-positive Japanease patient with reactive arthritis","volume":"33","author":"Nanke","year":"2010","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0270","first-page":"936","article-title":"Reiter's disease. Effective combination drug therapy with methotrexate, etretinate and prednisolone","volume":"125","author":"Luderschmidt","year":"1983","journal-title":"MMW Munch Med Wochenschr"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.38.1.48","article-title":"Methotrexate in Reiter's disease","volume":"38","author":"Owen","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0280","first-page":"136","article-title":"Reiter's disease, responding to methotrexate","volume":"18","author":"Chee","year":"1977","journal-title":"Singapore Med J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0285","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0190-9622(97)80235-6","article-title":"Successful treatment of severe recurrent Reiter's syndrome with cyclosporine","volume":"36","author":"Kiyohara","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0290","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.30272","article-title":"Safety and efficacy of anti-tumor necrosis factor alpha therapy in ten patients with recent-onset refractory reactive arthritis","volume":"63","author":"Meyer","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0295","first-page":"1426","article-title":"The concept, definition and diagnostic criteria of sarcoidosis","volume":"52","author":"Yamamoto","year":"1994","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0300","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0310","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.0954-6820.1964.tb05713.x","article-title":"Epidemiologic studies on sarcoidosis in Denmark based on a nation-wide central register. A preliminary report","volume":"425","author":"Alsbirk","year":"1964","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0315","first-page":"50","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/oxfordjournals.aje.a114313","article-title":"The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival","volume":"123","author":"Henke","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/oxfordjournals.epirev.a036255","article-title":"Epidemiology of sarcoidosis","volume":"5","author":"Bresnitz","year":"1983","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0330","first-page":"118","article-title":"Sarcoidosis in Spain","volume":"9","author":"Mana","year":"1992","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0335","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1749-6632.1976.tb47090.x","article-title":"Description of sarcoidosis: report of the Subcommittee on Classification and Definition","volume":"278","author":"James","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0340","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0345","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and Other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0350","doi-asserted-by":"crossref","first-page":"699.e1","DOI":"10.1016\/j.jaad.2011.11.965","article-title":"Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease","volume":"66","author":"Haimovic","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0355","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0041-3879(73)90030-5","article-title":"Familial associations in sarcoidosis. A report to the Research Committee of the British Thoracic and Tuberculosis Association","volume":"54","year":"1973","journal-title":"Tubercle"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0360","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-2-46","article-title":"Sarcoidosis","volume":"2","author":"Nunes","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0365","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clindermatol.2007.03.008","article-title":"Systemic evaluation of a potential cutaneous sarcoidosis patient","volume":"25","author":"Costabel","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0370","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0375","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/mjd.2001.114596","article-title":"Sarcoidosis","volume":"44","author":"English","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0380","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/pgmj.74.877.649","article-title":"Cutaneous sarcoidosis","volume":"74","author":"Wilson","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0385","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clindermatol.2007.03.007","article-title":"Chronic cutaneous lesions of sarcoidosis","volume":"25","author":"Marchell","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1985.tb04859.x","article-title":"Lupus pernio: a clinico-radiologic study of thirty-five cases","volume":"112","author":"Spiteri","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0395","first-page":"108","article-title":"Dermatologic aspects of sarcoidosis","volume":"28","author":"James","year":"1959","journal-title":"Q J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0400","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0190-9622(84)80202-9","article-title":"Hypopigmented lesions in sarcoidosis","volume":"11","author":"Hall","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0738-081X(86)90032-5","article-title":"Cutaneous sarcoidosis: definitions and types of lesions","volume":"4","author":"Elgart","year":"1986","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0410","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archinte.1985.00360100071011","article-title":"Cutaneous manifestations of sarcoidosis. Relationships to other organ system involvement, abnormal laboratory measurements, and disease course","volume":"145","author":"Olive","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0415","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007611-197706000-00009","article-title":"Unusual cutaneous manifestations of sarcoidosis","volume":"70","author":"Greer","year":"1977","journal-title":"South Med J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D39PT7X94S","article-title":"Cicatricial alopecia due to sarcoidosis","volume":"9","author":"Douri","year":"2003","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0425","first-page":"862","article-title":"Ichthyosiform sarcoidosis","volume":"40","author":"Cather","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0430","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2133.2005.06815.x","article-title":"Subcutaneous sarcoidosis\u2014clinicopathological study of 10 cases","volume":"153","author":"Marcoval","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0435","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1997.03890380087013","article-title":"Ulcerative sarcoidosis. Case report and review of the literature","volume":"133","author":"Albertini","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0440","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2230.1994.tb01259.x","article-title":"Erythema nodosum-like eruption in sarcoidosis","volume":"19","author":"Okamoto","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0445","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.rdc.2013.02.007","article-title":"Extrapulmonary manifestations of sarcoidosis","volume":"39","author":"Rao","year":"2013","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0450","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0455","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0039-6257(86)90118-9","article-title":"Pediatric ocular sarcoidosis","volume":"30","author":"Hoover","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0460","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0465","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0470","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0002-9394(78)90184-8","article-title":"Sarcoidosis and its ophthalmic manifestations","volume":"86","author":"Obenauf","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0475","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ICU.0b013e328358c7a6","article-title":"Different ophthalmologic manifestations of sarcoidosis","volume":"23","author":"Umur","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-012-2078-1","article-title":"Retinal vasculitis in rheumatic diseases: an unseen burden","volume":"32","author":"Androudi","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0485","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajo.2010.12.011","article-title":"Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases","volume":"151","author":"Demirci","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0490","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2013.3343","article-title":"Practice gaps. The dermatologist's role in sarcoidosis","volume":"149","author":"Rosenbach","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0495","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2010.05.022","article-title":"Preventing vitamin D toxicity in patients with sarcoidosis","volume":"64","author":"Sage","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0500","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaad.2011.04.026","article-title":"Thyroid dysfunction and cutaneous sarcoidosis","volume":"66","author":"Anolik","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0505","first-page":"69","article-title":"Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing","volume":"72","author":"Volden","year":"1992","journal-title":"Acta Dermatovenerol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0510","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archderm.1995.01690170121026","article-title":"Lupus pernio: successful treatment with a potent topical corticosteroid","volume":"131","author":"Khatri","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0515","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0190-9622(81)70017-3","article-title":"Intralesional corticosteroids","volume":"4","author":"Callen","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0520","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0738-081X(86)90036-2","article-title":"Cutaneous sarcoidosis: prognosis and treatment","volume":"4","author":"Veien","year":"1986","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0525","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.0954-6820.1964.tb05780.x","article-title":"Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis","volume":"425","author":"Siltzbach","year":"1964","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0530","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2013.2977","article-title":"Oral minocycline in treatment of cutaneous sarcoidosis","volume":"149","author":"Steen","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0535","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2012.10.056","article-title":"A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis","volume":"68","author":"Pariser","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0540","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0545","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.sder.2007.02.008","article-title":"Necrobiotic xanthogranuloma","volume":"26","author":"Fernandez-Herrera","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0550","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(80)80189-7","article-title":"Necrobiotic xanthogranuloma with paraproteinemia","volume":"3","author":"Kossard","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0555","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3171\/jns.2004.100.6.1111","article-title":"Necrobiotic xanthogranuloma with cutaneous and cerebral manifestations. Case report and review of the literature","volume":"100","author":"Shah","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0560","first-page":"342","article-title":"Necrobiotic xanthogranuloma with paraproteinemia: case report and a pathogenetic theory","volume":"84","author":"Bullock","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0565","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9150(98)00260-3","article-title":"Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia\u2014a possible pathogenesis of necrobiotic xanthogranuloma","volume":"142","author":"Matsuura","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0570","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1992.01680110104016","article-title":"Necrobiotic xanthogranuloma","volume":"128","author":"Mehregan","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0575","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9394(99)00469-9","article-title":"Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement","volume":"129","author":"Ugurlu","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0580","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.wno.0000177299.44845.65","article-title":"Necrobiotic xanthogranuloma associated with choroidal infiltration and syncytial giant cell hepatitis","volume":"25","author":"Amer","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0585","first-page":"341","article-title":"Systemic necrobiotic xanthogranuloma with initial pericardial and pulmonary involvement","volume":"130","author":"Bara","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0590","first-page":"700","article-title":"Necrobiotic xanthogranuloma","volume":"9","author":"Efebera","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0595","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2133.1995.tb02674.x","article-title":"Necrobiotic xanthogranuloma with cardiac involvement","volume":"133","author":"Umbert","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0600","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4065\/72.11.1028","article-title":"Giant cell granulomatous pulmonary and myocardial lesions in necrobiotic xanthogranuloma with paraproteinemia","volume":"72","author":"Winkelmann","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0605","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2004.12.016","article-title":"Necrobiotic xanthogranuloma: isolated skeletal muscle involvement and unusual changes","volume":"52","author":"Yasukawa","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4632.2009.03912.x","article-title":"Necrobiotic xanthogranuloma","volume":"48","author":"Spicknall","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0615","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2230.2001.00873.x","article-title":"Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation","volume":"26","author":"Chave","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0620","first-page":"122","article-title":"Necrobiotic xanthogranuloma of the extremities","volume":"11","author":"Wolz","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0625","first-page":"47","article-title":"Necrobiotic xanthogranuloma associated with a benign monoclonal gammopathy","volume":"72","author":"Burdick","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0630","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archderm.133.1.99","article-title":"Periorbital papules and nodules. Necrobiotic xanthogranuloma","volume":"133","author":"Lebey","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0635","first-page":"357","article-title":"Necrobiotic xanthogranuloma with orbital involvement","volume":"85","author":"Luck","year":"1992","journal-title":"J R Soc Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0640","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IOP.0b013e3181d92955","article-title":"Necrobiotic xanthogranuloma with predominant periorbital involvement","volume":"26","author":"Oestreicher","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0645","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archdermatol.2008.583","article-title":"Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation","volume":"145","author":"Wood","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0650","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/DAD.0b013e318234e73c","article-title":"Necrobiotic xanthogranuloma associated with necrotizing scleritis","volume":"34","author":"Peyman","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0655","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0161-6420(92)32031-7","article-title":"Varied clinical spectrum of necrobiotic xanthogranuloma","volume":"99","author":"Cornblath","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0660","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2005.085894","article-title":"Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review","volume":"90","author":"Sivak-Callcott","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0665","first-page":"1158","article-title":"Diffuse plane normolipemic xanthomatosis and necrobiotic xanthogranuloma associated with monoclonal gammopathy\u2014determining the disease stage with PET-CT and treatment experience. Two case studies and literature review","volume":"56","author":"Adam","year":"2010","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0670","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0248-8663(02)00594-5","article-title":"Necrobiotic xanthogranuloma, a cutaneous disorder associated with monoclonal gammopathy","volume":"23","author":"Roth","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1076\/orbi.23.1.65.28989","article-title":"Upper and lower eyelid reconstruction for severe disfiguring necrobiotic xanthogranuloma","volume":"23","author":"Schaudig","year":"2004","journal-title":"Orbit"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0680","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/DAD.0b013e3182051fce","article-title":"Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjogren syndrome","volume":"33","author":"Naghashpour","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0685","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-4632.2006.02575.x","article-title":"Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: the first case reported in the literature and review of the literature","volume":"45","author":"Oumeish","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0690","first-page":"182","article-title":"Necrobiotic xanthogranuloma associated with lymphoplasmacytic lymphoma. Palliative treatment with carbon dioxide laser","volume":"15","author":"Vieira","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0695","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jbspin.2005.03.008","article-title":"Necrobiotic xanthogranuloma with multiple myeloma. Case report and pathogenic hypotheses","volume":"73","author":"Langlois","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0700","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1468-3083.2004.00906.x","article-title":"Necrobiotic xanthogranuloma associated with myeloma","volume":"18","author":"Martinez Fernandez","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0705","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2230.2009.03447.x","article-title":"Necrobiotic xanthogranuloma without paraproteinaemia: marked improvement with psoralen ultraviolet A treatment","volume":"35","author":"Al-Niaimi","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0710","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0190-9622(87)70211-4","article-title":"Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma","volume":"17","author":"Finelli","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0715","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archdermatol.2010.236","article-title":"Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin","volume":"146","author":"Hallermann","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0720","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2310\/7750.2013.13012","article-title":"Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin","volume":"17","author":"Rubinstein","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0725","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0190-9622(95)90370-4","article-title":"Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia","volume":"32","author":"Venencie","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0730","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/IOP.0b013e31827ae96a","article-title":"Adult-onset asthma associated with periocular xanthogranuloma: new diagnostic and therapeutic approaches in a very rare systemic disease","volume":"29","author":"London","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0735","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archdermatol.2011.279","article-title":"A case of adult-onset asthma with periocular xanthogranulomas","volume":"147","author":"Agi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0740","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1750-1172-8-137","article-title":"Erdheim-Chester disease: a comprehensive review of the literature","volume":"8","author":"Mazor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0745","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0560.2010.01650.x","article-title":"Erdheim-Chester disease presenting with cutaneous involvement: a case report and literature review","volume":"38","author":"Volpicelli","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0750","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archderm.144.6.803","article-title":"Association of inflammatory eye disease with granuloma annulare?","volume":"144","author":"Brey","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0755","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.1982.01650130071028","article-title":"Perforating granuloma annular and scleritis","volume":"118","author":"Dick","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0760","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.lpm.2011.08.006","article-title":"Simultaneous occurrence of generalized granuloma annulare, anterior uveitis and giant cell arteritis: coincidental or not?","volume":"41","author":"Kluger","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0765","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09273940801899814","article-title":"Granuloma annulare anterior uveitis","volume":"16","author":"Reddy","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0770","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/112067210301300116","article-title":"Uveitis associated with granuloma annulare","volume":"13","author":"Oz","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(88)70001-8","article-title":"Amyloid and amyloidosis","volume":"18","author":"Breathnach","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0780","first-page":"193","article-title":"Primary systemic amyloidosis associated with multiple myeloma: a case report and review of the literature","volume":"80","author":"Mason","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0785","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0790","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/DAD.0b013e31823465c7","article-title":"Cutaneous amyloidosis: a concept review","volume":"34","author":"Fernandez-Flores","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0795","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1258\/acb.2011.011225","article-title":"Amyloidosis","volume":"49","author":"Pinney","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0800","first-page":"96","article-title":"Cutaneous amyloidosis","volume":"9","author":"Borowicz","year":"2011","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0805","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-4632.2004.01935.x","article-title":"Macular amyloidosis: an assessment of prevalence, sex, and age","volume":"43","author":"Rasi","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0810","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0738-081X(90)90082-C","article-title":"Clinical features of cutaneous amyloidoses","volume":"8","author":"Wang","year":"1990","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0815","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-88-6-781","article-title":"Skin involvement in generalized amyloidosis. A study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis","volume":"88","author":"Rubinow","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0820","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0825","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1346-8138.2008.00487.x","article-title":"Systemic amyloidosis associated with multiple myeloma presenting as periorbital purpura","volume":"35","author":"Lee","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0190-9622(98)70069-6","article-title":"Cutaneous deposition diseases. Part I","volume":"39","author":"Touart","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0835","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archderm.1981.01650120061028","article-title":"Alopecia universalis. A manifestation of occult amyloidosis and multiple myeloma","volume":"117","author":"Wheeler","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0840","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1440-0960.2002.00579.x","article-title":"Myeloma-associated systemic amyloidosis presenting with acquired digital cutis laxa-like changes","volume":"43","author":"Dicker","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0845","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0190-9622(80)80117-4","article-title":"Bullous amyloidosis","volume":"3","author":"Beacham","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0850","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2133.1997.tb03764.x","article-title":"Nail changes as the only skin abnormality in myeloma-associated systemic amyloidosis","volume":"137","author":"Mancuso","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0855","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.IOP.0000117289.58438.FC","article-title":"Review: orbital amyloidosis","volume":"20","author":"Taban","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0860","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/01676830.2012.707740","article-title":"Amyloidosis of the orbit and adnexae","volume":"31","author":"Al-Nuaimi","year":"2012","journal-title":"Orbit"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0865","first-page":"367","article-title":"Amyloidosis of the orbit and adnexae","volume":"19","author":"Knowles","year":"1975","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0870","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1684\/ejd.2010.0842","article-title":"Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement","volume":"20","author":"Schreml","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0875","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0880","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0885","doi-asserted-by":"crossref","first-page":"355.e15","DOI":"10.1016\/j.amjmed.2005.08.043","article-title":"Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis","volume":"119","author":"Hazenberg","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0890","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","article-title":"The multiple faces of Behcet's disease and its aetiological factors","volume":"15","author":"Onder","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0895","first-page":"S53","article-title":"Prevalence of Behcet's disease in rural western Turkey: a preliminary report","volume":"22","author":"Cakir","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0900","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Behcet's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0905","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2009.108571","article-title":"Genetics of Behcet disease inside and outside the MHC","volume":"69","author":"Meguro","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0910","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0915","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0920","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/Classification Criteria for Behcet's Disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Pathol Res Int"},{"issue":"3","key":"10.1016\/j.clindermatol.2015.11.013_bb0925","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70523-2","article-title":"Behcet's disease and complex aphthosis","volume":"40","author":"Ghate","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0935","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0190-9622(95)91333-5","article-title":"Mucocutaneous criteria for the diagnosis of Behcet's disease: an analysis of clinicopathologic data from multiple international centers","volume":"32","author":"Jorizzo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0940","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0190-9622(08)81073-0","article-title":"Behcet's disease","volume":"23","author":"Jorizzo","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0945","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1172-7-20","article-title":"Behcet's disease","volume":"7","author":"Saadoun","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0950","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","article-title":"Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study","volume":"157","author":"Alpsoy","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0955","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1309\/GCTH-0060-55K8-XCTT","article-title":"Clinicopathologic evaluation of nodular cutaneous lesions of Behcet syndrome","volume":"116","author":"Demirkesen","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0960","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000372-200010000-00001","article-title":"Histopathologic features of erythema nodosum\u2013like lesions in Behcet disease: a comparison with erythema nodosum focusing on the role of vasculitis","volume":"22","author":"Kim","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0965","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004397-200604620-00017","article-title":"Behcet disease","volume":"46","author":"Yates","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0970","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","article-title":"Ocular features of Behcet's disease: an international collaborative study","volume":"91","author":"Kitaichi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0975","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/08820530500231953","article-title":"Behcet's disease","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0980","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Behcet's disease","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0985","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archneur.1981.00510100071012","article-title":"Papilledema in Behcet's syndrome","volume":"38","author":"Pamir","year":"1981","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0990","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcet's disease: an update","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb0995","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3182428126","article-title":"Long-term outcome of arterial lesions in Behcet disease: a series of 101 patients","volume":"91","author":"Saadoun","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"Pt 11","key":"10.1016\/j.clindermatol.2015.11.013_bb1000","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurologic involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1005","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.clineuro.2013.06.009","article-title":"Characteristics of neurologic manifestations of Behcet's disease: a retrospective monocentric study in Tunisia","volume":"115","author":"Houman","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1010","first-page":"1542","article-title":"Neurological manifestations of Behcet's disease","volume":"27","author":"Borhani-Haghighi","year":"2006","journal-title":"Saudi Med J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000018426","article-title":"Adamantiades-Behcet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate","volume":"201","author":"Katsantonis","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1020","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","article-title":"Behcet's syndrome","volume":"72","author":"Dalvi","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000182257","article-title":"Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behcet's disease","volume":"218","author":"Kose","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","article-title":"A double-blind trial of depot corticosteroids in Behcet's syndrome","volume":"45","author":"Mat","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1040","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1045","first-page":"399","article-title":"A double blind study of colchicine in Behcet's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Behcet's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1065","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/26.4.285","article-title":"Cyclosporin A in the treatment of severe Behcet's uveitis","volume":"26","author":"Binder","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/09273948.2012.665124","article-title":"Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behcet's disease","volume":"20","author":"Takeuchi","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1080","first-page":"5","article-title":"Efficacy of infliximab in refractory Behcet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients","volume":"6","author":"Cantini","year":"2012","journal-title":"Biologics"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1085","first-page":"S58","article-title":"Long-term remission of ocular and extraocular manifestations in Behcet's disease using infliximab","volume":"29","author":"Handa","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/acr.21557","article-title":"Behcet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis","volume":"64","author":"Adler","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1095","first-page":"S99","article-title":"Infliximab for the treatment of resistant oral ulcers in Behcet's disease: a case report and review of the literature","volume":"25","author":"Almoznino","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1100","first-page":"S94","article-title":"Successful treatment of leg ulcers in Behcet's disease using adalimumab plus methotrexate after the failure of infliximab","volume":"28","author":"Atzeni","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","article-title":"Successful treatment of genital ulcers with infliximab in Behcet's disease","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1110","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","article-title":"Neurological manifestations of Behcet's disease: evaluation of 40 patients treated by cyclophosphamide","volume":"168","author":"Ait Ben Haddou","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1115","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10067-006-0385-0","article-title":"Low-dose intra-venous cyclophosphamide therapy in a patient with neurologic complications of Behcet's disease","volume":"26","author":"Melillo","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000056324","article-title":"Multiple pulmonary arterial aneurysms in Behcet's disease: clinical and radiologic remission after cyclophosphamide and corticosteroid therapy","volume":"69","author":"Aktogu","year":"2002","journal-title":"Respiration"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1125","first-page":"658","article-title":"Management of Behcet's disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet's disease","volume":"69","author":"Kotter","year":"2010","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon alpha in Behcet disease: review of the literature","volume":"33","author":"Kotter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/000331978703801007","article-title":"Cholesterol crystal embolization: a review of 221 cases in the English literature","volume":"38","author":"Fine","year":"1987","journal-title":"Angiology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1053\/ajkd.2000.19809","article-title":"Cholesterol crystal embolism: a recognizable cause of renal disease","volume":"36","author":"Scolari","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0002-9343(95)00059-3","article-title":"Redefining the incidence of clinically detectable atheroembolism","volume":"100","author":"Mayo","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1150","first-page":"549","article-title":"Arterial occlusions produced by emboli from eroded aortic atheromatous plaques","volume":"21","author":"Flory","year":"1945","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.109.886465","article-title":"Cholesterol embolization syndrome","volume":"122","author":"Kronzon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1160","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ki.5000263","article-title":"Cholesterol crystal embolism: Diagnosis and treatment","volume":"69","author":"Meyrier","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1165","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000168669","article-title":"Renal cholesterol embolic disease. Case report and review of the literature","volume":"13","author":"Lye","year":"1993","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1170","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/jcp.31.10.984","article-title":"Atheroembolism","volume":"31","author":"Kealy","year":"1978","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archinte.1996.00440060081009","article-title":"Cholesterol crystal embolization in the Netherlands","volume":"156","author":"Moolenaar","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1532-5415.1990.tb01427.x","article-title":"Renal biopsy in patients 65 years of age or older. An analysis of the results of 334 biopsies","volume":"38","author":"Preston","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1185","first-page":"261","article-title":"Atheromatous emboli in renal biopsies. An ultrastructural study","volume":"78","author":"Jones","year":"1975","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005792-198811000-00003","article-title":"Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature","volume":"67","author":"Colt","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(03)00579-5","article-title":"The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study","volume":"42","author":"Fukumoto","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11883-013-0315-y","article-title":"The cholesterol emboli syndrome in atherosclerosis","volume":"15","author":"Quinones","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM196904102801506","article-title":"Atheroembolic renal disease","volume":"280","author":"Kassirer","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1210","first-page":"317","article-title":"Atheroembolic renal disease: experience with 22 patients","volume":"79","author":"Frock","year":"1994","journal-title":"Nebr Med J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1215","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archderm.1986.01660220112024","article-title":"The cutaneous manifestations of cholesterol crystal embolization","volume":"122","author":"Falanga","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.1961.03040400025005","article-title":"Significance of bright plaques in the retinal arterioles","volume":"178","author":"Hollenhorst","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1225","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1001\/archinte.1987.00370080020004","article-title":"Eosinophilia as a clue to the diagnosis of atheroembolic renal disease","volume":"147","author":"Kasinath","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1230","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0272-6386(99)70415-4","article-title":"Supportive treatment improves survival in multivisceral cholesterol crystal embolism","volume":"33","author":"Belenfant","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1235","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0002-9149(02)02870-9","article-title":"Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque","volume":"90","author":"Tunick","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bmj.324.7332.268","article-title":"Improvement in cholesterol emboli syndrome after iloprost therapy","volume":"324","author":"Elinav","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1245","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00055735-200012000-00009","article-title":"Vogt-Koyanagi-Harada disease","volume":"11","author":"Read","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09273940600557001","article-title":"Management of pediatric Vogt-Koyanagi-Harada (VKH)\u2013associated panuveitis","volume":"14","author":"Soheilian","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200604620-00011","article-title":"Vogt-Koyanagi-Harada disease","volume":"46","author":"Andreoli","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1260","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1167\/iovs.04-1273","article-title":"T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis","volume":"46","author":"Damico","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/exer.2000.0893","article-title":"Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats","volume":"71","author":"Yamaki","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006982-199616020-00013","article-title":"Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome","volume":"16","author":"Bassili","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10792-006-9020-y","article-title":"Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease","volume":"27","author":"Sugita","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1280","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.mlg.0000234946.31603.fe","article-title":"Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome","volume":"116","author":"Ondrey","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000018067","article-title":"Vogt-Koyanagi-Harada disease: extensive vitiligo with prodromal generalized erythroderma","volume":"198","author":"Wong","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1067\/mjd.2001.110879","article-title":"Inflammatory vitiligo in Vogt-Koyanagi-Harada disease","volume":"44","author":"Tsuruta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1295","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1167\/iovs.11-8984","article-title":"Optic disc swelling in Vogt-Koyanagi-Harada disease","volume":"53","author":"Nakao","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1300","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9394(00)00851-5","article-title":"Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease","volume":"131","author":"Inomata","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1305","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0161-6420(81)34891-X","article-title":"Sugiura's sign. Perilimbal vitiligo in the Vogt-Koyanagi-Harada syndrome","volume":"88","author":"Friedman","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1310","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1315","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/IAE.0b013e3181eef053","article-title":"Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1320","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1097\/IAE.0b013e318256205a","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease","volume":"32","author":"Nakayama","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/IIO.0b013e31826908fb","article-title":"Imaging in the diagnosis and management of Vogt-Koyanagi-Harada disease","volume":"52","author":"Jap","year":"2012","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1330","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0161-6420(93)31506-X","article-title":"Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome","volume":"100","author":"Kahn","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9394(77)90623-7","article-title":"Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome","volume":"83","author":"Perry","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10792-006-9029-2","article-title":"Pathology of Vogt-Koyanagi-Harada disease","volume":"27","author":"Rao","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1345","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00190711","article-title":"Vitiligo in Vogt-Koyanagi-Harada disease: Immunohistological analysis of inflammatory site","volume":"234","author":"Okada","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1355","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/120347540000400309","article-title":"Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease","volume":"4","author":"DiPreta","year":"2000","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1360","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/09273948.2013.775312","article-title":"Successful use of infliximab therapy in sight-threatening corticosteroid-resistant Vogt-Koyanagi-Harada disease","volume":"21","author":"Zmuda","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12348-011-0027-9","article-title":"Rituximab in refractory Vogt-Koyanagi-Harada disease","volume":"1","author":"Dolz-Marco","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1370","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1380","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1985.1.369","article-title":"Cyclosporine therapy for uveitis: long-term followup","volume":"1","author":"Nussenblatt","year":"1985","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1385","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0161-6420(96)30683-0","article-title":"Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis","volume":"103","author":"Vitale","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1390","first-page":"1589","article-title":"Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada disease","volume":"5","author":"Byon","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1395","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/112067210601600322","article-title":"Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome","volume":"16","author":"Karacorlu","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1400","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","article-title":"Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome","volume":"137","author":"Andrade","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1405","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/014556131109001206","article-title":"Intratympanic steroid use for hearing salvage in Vogt-Koyanagi-Harada syndrome","volume":"90","author":"Pelosi","year":"2011","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1410","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archopthalmol.2011.1520","article-title":"Reversal of poliosis and vitiligo following Vogt-Koyanagi-Harada disease","volume":"130","author":"Tabbara","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1415","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-5155(98)00066-5","article-title":"Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease","volume":"43","author":"Sonoda","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1420","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0161-6420(00)00244-X","article-title":"Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease","volume":"107","author":"Kuo","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1425","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.dad.0000181109.54532.c5","article-title":"Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis","volume":"27","author":"Carlson","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1435","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1440","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0738-081X(99)00074-7","article-title":"A clinical approach to the vasculitis patient in the dermatologic office","volume":"17","author":"Callen","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1445","first-page":"144","article-title":"Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview","volume":"86","author":"Kawakami","year":"2006","journal-title":"Acta Dermatovenerol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1450","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-94-007-4546-9_39","article-title":"Cutaneous changes: an initial manifestation of pulmonary Wegener's granulomatosis","volume":"755","author":"Zycinska","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1455","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejim.2009.04.007","article-title":"\"Strawberry like\" gingivitis being the first sign of Wegener's granulomatosis","volume":"20","author":"Ruokonen","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1460","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.survophthal.2009.12.003","article-title":"Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease","volume":"55","author":"Tarabishy","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1465","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0190-9622(82)70094-5","article-title":"Giant cell arteritis: a systemic disease with rare cutaneous manifestations","volume":"6","author":"Baum","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1470","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/0019-5154.113980","article-title":"Bitemporal scalp, lip and tongue necrosis in giant cell arteritis: a rare presentation","volume":"58","author":"Kumar","year":"2013","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1475","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00393-012-1009-5","article-title":"Bitemporal scalp necrosis: a very rare manifestation of giant cell arteritis","volume":"71","author":"Valesky","year":"2012","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1480","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1100\/tsw.2011.123","article-title":"Giant cell arteritis presenting as scalp necrosis","volume":"11","author":"Maidana","year":"2011","journal-title":"Sci World J"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1485","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3899\/jrheum.110780","article-title":"Necrotic tongue: a rare manifestation of giant cell arteritis","volume":"38","author":"Jennings","year":"2011","journal-title":"J Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/j.clindermatol.2015.11.013_bb1490","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/s10067-009-1141-z","article-title":"Tongue necrosis as first symptom of giant cell arteritis (GCA)","volume":"28","author":"Brodmann","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1495","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archderm.1970.04000040031007","article-title":"Dermatologic manifestations of giant-cell (temporal, cranial) arteritis","volume":"101","author":"Hitch","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1500","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.berh.2004.09.001","article-title":"Classification and diagnostic criteria in systemic vasculitis","volume":"19","author":"Saleh","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1505","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ICU.0b013e32833eae8b","article-title":"Diagnosis and management of giant cell arteritis: a review","volume":"21","author":"Kale","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1510","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.27240","article-title":"Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database","volume":"62","author":"Pagnoux","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1515","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0161-6420(93)31405-3","article-title":"Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy","volume":"100","author":"Akova","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1520","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/pde.12034","article-title":"Granulomatosis with polyangiitis (Wegener's granulomatosis) in children: report of three cases with cutaneous manifestations and literature review","volume":"30","author":"Gajic-Veljic","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.dad.0000245198.80847.ff","article-title":"Cutaneous vasculitis update: Neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes","volume":"29","author":"Carlson","year":"2007","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1530","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1535","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7861\/clinmedicine.13-3-321a","article-title":"Churg-Strauss syndrome: remember cardiac complications too","volume":"13","author":"Medford","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1545","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","article-title":"Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients","volume":"84","author":"Guillevin","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1550","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0168-8278(00)80025-2","article-title":"Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine","volume":"33","author":"Erhardt","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1555","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004836-199504000-00026","article-title":"Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone","volume":"20","author":"Simsek","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","article-title":"Primary systemic vasculitis: clinical features and mortality","volume":"98","author":"Lane","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1565","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s001050050999","article-title":"High dosage intravenous immunoglobulin (IVIG) therapy in therapy-refractory ANCA-negative, necrotizing vasculitis","volume":"50","author":"Altmeyer","year":"1999","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1570","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1575","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1580","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semarthrit.2013.07.010","article-title":"Biological therapy for systemic vasculitis: a systematic review","volume":"43","author":"Silva-Fernandez","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1585","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1590","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2009.10.014","article-title":"Sustained response to mepolizumab in refractory Churg-Strauss syndrome","volume":"125","author":"Kahn","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1595","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nrl.2010.03.009","article-title":"Temporal arteritis: treatment controversies","volume":"25","author":"Balsalobre Aznar","year":"2010","journal-title":"Neurologia"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1600","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10067-006-0375-2","article-title":"Treatment of refractory temporal arteritis with adalimumab","volume":"26","author":"Ahmed","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2015.11.013_bb1605","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11936-006-0007-9","article-title":"Current diagnosis and treatment of temporal arteritis","volume":"8","author":"Schmidt","year":"2006","journal-title":"Curr Treat Options Cardiovasc Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X15002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:19:39Z","timestamp":1718209179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X15002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":321,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0738081X15002382"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multisystem diseases affecting the skin and eye","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}